Glycopyrrolate 0.025mg


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Treatment of Chronic obstructive pulmonary disease (COPD)COPD (chronic obstructive pulmonary disease) is a group of lung diseases that cause breathing difficulties. COPD is caused by swelling of the airways that carry air in and out of the lungs. Zenismart-G25 Ampoules (2ml Each) relaxes the muscles of these airways and widens it. This makes you breathe easy and gives relief from symptoms such as tightness in your chest, shortness of breath, wheezing and coughing. Avoid smoking and minimise your exposure to pollution, dust and fumes. Along with that, a little exercise each day can help you stay strong. Talk to your doctor about how much exercise is good for you.
Side effects of Zenismart-G Solution for inhalation The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Zenismart-GSore throat Dryness in mouth Insomnia (difficulty in sleeping)Gastroenteritis
How to use Zenismart-G Solution for inhalation Use it as advised by your doctor or check the label for directions before use.
How Zenismart-G Solution for inhalation works Zenismart-G25 Ampoules (2ml Each) is an anticholinergic medication. It works by blocking the activity of a chemical messenger (acetylcholine) in the brain.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Zenismart-G25 Ampoules (2ml Each) . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Zenismart-G25 Ampoules (2ml Each) is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Zenismart-G25 Ampoules (2ml Each) is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.Long-term use of Zenismart-G25 Ampoules (2ml Each) might reduce milk production.
No interaction found/established
No interaction found/established
No interaction found/established
Glycopyrrolate (28 Jan. 2025)
Memorial Sloan Kettering Cancer Center. Glycopyrrolate: Patient & Caregiver Education (28 Jan. 2025)
Glycopyrrolate (28 Jan. 2025)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.